An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.10.1097/00003246-200107000-0000211445675Search in Google Scholar

2. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946-55.10.1097/01.CCM.0000057403.73299.A612627010Search in Google Scholar

3. Bone R, Balk R, Cerra F, et al. Definitions for sepsisand organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of ChestPhysicians / Society of Critical Care Medicine”. Chest. 1992;101: 1644-55.10.1378/chest.101.6.16441303622Search in Google Scholar

4. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: Sampling, selection, and society. Crit Care. 2004;8:222-6.10.1186/cc291752285915312201Search in Google Scholar

5. Hervald H, Egesten A. Sepsis. Pro-Inflammatory and Anti- Inflammatory Responses. Controb Microbiol. Basel, Krager, 2011, vol 17, pp 1-11.10.1159/isbn.978-3-8055-9711-1Search in Google Scholar

6. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsisand septic shock: 2012. Crit Care Med. 2013;41:580-637.10.1097/CCM.0b013e31827e83af23353941Search in Google Scholar

7. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, et al. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care. 2004; 19:152-7.Search in Google Scholar

8. James D. Faix. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50:23-36.10.3109/10408363.2013.764490361396223480440Search in Google Scholar

9. Szederjesi J, Almasy E, Lazar A, Huțanu A, Georgescu A. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis. J Crit Care Med. 2015;1:18-23.10.1515/jccm-2015-0004595328029967811Search in Google Scholar

10. Schröder J, Staubach KH, Zabel P, Stüber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg. 1999;384:33-8.10.1007/s00423005017010367627Search in Google Scholar

11. Enguix-Armada A, Escobar-Conesa R, La Torre AG, De La Torre- Prados MV. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clin Chem Lab Med. 2015 17. pii: /j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print]10.1515/cclm-2015-024326083268Search in Google Scholar

12. Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013;40:358-65.10.1097/SHK.0b013e3182a66bd6380604724088989Search in Google Scholar

13. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ ATS/ SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31:1250-6.10.1097/01.CCM.0000050454.01978.3B12682500Search in Google Scholar

14. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-53.10.1097/01.CCM.0000194725.48928.3ASearch in Google Scholar

15. Nargis W, Ibrahim Md, Adamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4:195-9.10.4103/2229-5151.141356420054425337480Search in Google Scholar

16. Koenig SM, Truwit JD. Ventilator-Associated Pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19:637-57.10.1128/CMR.00051-05159269417041138Search in Google Scholar

17. Magill SS, Dumyati G, Ray SM, Fridkin SK. Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States. Emerg Infect Dis. 2015;21:1537-42.10.3201/eid2109.150508455013726291035Search in Google Scholar

18. Que YA, Guessous I, Dupuis-Lozeron E, et al. Prognostication of Mortality in Critically Ill Patients With Severe Infections. Chest. 2015;148:674-82.10.1378/chest.15-012326065577Search in Google Scholar

19. Enguix-Armada A, Escobar-Conesa R, La Torre AG et al. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and midregional pro-adrenomedullin. Clin Chem Lab Med. 2015. pii:/j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print].10.1515/cclm-2015-024326083268Search in Google Scholar

20. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults. A Multicenter {rospective Study in Intensive Care Units. JAMA. 1995;274:968-74.10.1001/jama.1995.03530120060042Search in Google Scholar

21. Hinriksdóttir G, Tryggvadóttir Á, Ólafsdóttir AS, et al. Fatness but Not Fitness Relative to the Fat-Free Mass Is Related to C-Reactive Protein in 18 Year-Old Adolescents. PLoS One. 2015;10:e0130597. doi: 10.1371/journal.pone.0130597. eCollection 2015.10.1371/journal.pone.0130597446806726075745Search in Google Scholar

22. Parrett AL, Valentine RJ, Arngrímsson SA et al. Adiposity, activity, fitness, and C-reactive protein in children. Med Sci Sports Exerc. 2010;42:1981-6.10.1249/MSS.0b013e3181e0355e20386340Search in Google Scholar

23. Waheeda Nargis, Md Ibrahim, Borhan Uddin Ahamed. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit. 2014;4:195-9.10.4103/2229-5151.141356420054425337480Search in Google Scholar

24. Akcay I, Okoh AK, Yalav O, et al. The prognostic value of procalcitonin, CRP and thyroid hormones in secondary peritonitis: a single-center prospective study. Ulus Travma Acil Cerrahi Derg. 2014;20:343-352. 10.5505/tjtes.2014.9835425541846Search in Google Scholar